<?xml version="1.0" encoding="utf-8"?>
<rr:ResultsReport>
	<rr:ResultsPayload>
		<FinalReport>
			<Sample>
				<FM_Id>AA -24-00393</FM_Id>
				<SampleId></SampleId>
				<BlockId>M113-10019_(PT24002)</BlockId>
				<TRFNumber></TRFNumber>
				<TestType></TestType>
				<SpecFormat>Liver  Type</SpecFormat>
				<ReceivedDate>Jan 18, 2024</ReceivedDate>
			</Sample>
			<PMI>
				<ReportId></ReportId>
				<MRN>***46325</MRN>
				<FullName>謝*賦</FullName>
				<FirstName></FirstName>
				<LastName></LastName>
				<SubmittedDiagnosis>Hepatocellular carcinoma</SubmittedDiagnosis>
				<Gender>Male</Gender>
				<DOB>Apr **, 1963</DOB>
				<OrderingMD>黃怡翔醫師</OrderingMD>
				<OrderingMDId></OrderingMDId>
				<Pathologist></Pathologist>
				<CopiedPhysician1></CopiedPhysician1>
				<MedFacilName>臺北榮總</MedFacilName>
				<MedFacilID></MedFacilID>
				<SpecSite></SpecSite>
				<CollDate></CollDate>
				<ReceivedDate></ReceivedDate>
				<CountryOfOrigin></CountryOfOrigin>
			</PMI>
		</FinalReport>
		<variant-report>
			<short_variants>
				<short_variant>
					<cds_effect>c.8187G&gt;T</cds_effect>
					<depth>835</depth>
					<gene>BRCA2</gene>
					<percent_reads>47.4%</percent_reads>
					<protein_effect>K2729N</protein_effect>
					<transcript>NM_000059</transcript>
				</short_variant>
				<short_variant>
					<cds_effect>c.2888G&gt;C</cds_effect>
					<depth>634</depth>
					<gene>EPHA5</gene>
					<percent_reads>48.4%</percent_reads>
					<protein_effect>G963A</protein_effect>
					<transcript>NM_001281765</transcript>
				</short_variant>
				<short_variant>
					<cds_effect>c.3590T&gt;A</cds_effect>
					<depth>780</depth>
					<gene>ERBB2</gene>
					<percent_reads>23.3%</percent_reads>
					<protein_effect>L1197*</protein_effect>
					<transcript>NM_004448</transcript>
				</short_variant>
				<short_variant>
					<cds_effect>c.985G&gt;A</cds_effect>
					<depth>488</depth>
					<gene>FGFR3</gene>
					<percent_reads>56.1%</percent_reads>
					<protein_effect>V329I</protein_effect>
					<transcript>NM_000142</transcript>
				</short_variant>
				<short_variant>
					<cds_effect>c.871C&gt;A</cds_effect>
					<depth>858</depth>
					<gene>HNF1A</gene>
					<percent_reads>57.0%</percent_reads>
					<protein_effect>P291T</protein_effect>
					<transcript>NM_000545</transcript>
				</short_variant>
				<short_variant>
					<cds_effect>c.4141G&gt;A</cds_effect>
					<depth>1671</depth>
					<gene>MET</gene>
					<percent_reads>46.1%</percent_reads>
					<protein_effect>A1381T</protein_effect>
					<transcript>NM_001127500</transcript>
				</short_variant>
				<short_variant>
					<cds_effect>c.613T&gt;G</cds_effect>
					<depth>925</depth>
					<gene>MYD88</gene>
					<percent_reads>26.5%</percent_reads>
					<protein_effect>C205G</protein_effect>
					<transcript>NM_002468</transcript>
				</short_variant>
				<short_variant>
					<cds_effect>c.1126T&gt;A</cds_effect>
					<depth>2405</depth>
					<gene>NTRK3</gene>
					<percent_reads>26.9%</percent_reads>
					<protein_effect>Y376N</protein_effect>
					<transcript>NM_001012338</transcript>
				</short_variant>
				<short_variant>
					<cds_effect>c.4948C&gt;G</cds_effect>
					<depth>519</depth>
					<gene>PTPRD</gene>
					<percent_reads>42.2%</percent_reads>
					<protein_effect>R1650G</protein_effect>
					<transcript>NM_002839</transcript>
				</short_variant>
				<short_variant>
					<cds_effect>c.25G&gt;T</cds_effect>
					<depth>403</depth>
					<gene>SDHD</gene>
					<percent_reads>18.6%</percent_reads>
					<protein_effect>A9S</protein_effect>
					<transcript>NM_003002</transcript>
				</short_variant>
				<short_variant>
					<cds_effect>c.4030_4032del</cds_effect>
					<depth>1226</depth>
					<gene>TSC2</gene>
					<percent_reads>48.0%</percent_reads>
					<protein_effect>E1344del</protein_effect>
					<transcript>NM_000548</transcript>
				</short_variant>
			</short_variants>
			<copy_number_alterations>
				<copy_number_alteration>
					<copy_number>0</copy_number>
					<gene>PTEN</gene>
					<position>Chr10</position>
					<type>Homozygous deletion</type>
				</copy_number_alteration>
				<copy_number_alteration>
					<copy_number>0</copy_number>
					<gene>CDKN2A</gene>
					<position>Chr9</position>
					<type>Homozygous deletion</type>
				</copy_number_alteration>
				<copy_number_alteration>
					<copy_number>1</copy_number>
					<gene>FLCN</gene>
					<position>Chr17</position>
					<type>Heterozygous deletion</type>
				</copy_number_alteration>
				<copy_number_alteration>
					<copy_number>72</copy_number>
					<gene>CCND1, FGF19</gene>
					<position>Chr11</position>
					<type>Amplification</type>
				</copy_number_alteration>
			</copy_number_alterations>
			<rearrangements>
			</rearrangements>
			<biomarkers>
				<microsatellite_instability>
					<status>Microsatellite stable (MSS)</status>
				</microsatellite_instability>
				<tumor_mutation_burden>
					<score>1.9</score>
				</tumor_mutation_burden>
			</biomarkers>
		</variant-report>
	</rr:ResultsPayload>
</rr:ResultsReport>